The new therapy is being hailed as a breakthrough. But the small study has some limitations – and hasn’t been peer-reviewed.

After years of heartbreak, researchers have found an experimental treatment that can slow the progression of Huntington’s ...

This is the first treatment of any kind to convincingly demonstrate slowing of progression in Huntington’s disease." ...

I cried with every single patient,” Sung says. “It just was this crazy feeling that, for the patients and families, almost can’t feel real.” The treatment, known as AMT-130, is delivered deep into the ...

Huntington's disease is a fatal, hereditary neurological disorder mostly striking people between the ages of 30 and 50.

A new gene therapy treatment developed by uniQuire has shown promise in reducing the progression of Huntington's Disease by ...

A company called uniQure has announced promising results from a trial of a new gene therapy for Huntington's disease. The ...

A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported.

A one-time gene therapy called AMT-130 helped slow the progression of Huntington's disease by 75%, paving the way for the ...

Stunning success in halting Huntington's disease with gene therapy offers new hope to those with the disorder—and promises ...

New gene therapy offers hope for Huntington's disease, potentially increasing quality of life significantly. Trial results ...

In a study reported by Uniqure, which developed the experimental gene therapy, scientists found that it slowed progression of ...